Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Journey Medical (DERM) Assets Average: 2021-2025

Historic Assets Average for Journey Medical (DERM) over the last 4 years, with Sep 2025 value amounting to $83.2 million.

  • Journey Medical's Assets Average rose 28.72% to $83.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $83.2 million, marking a year-over-year increase of 28.72%. This contributed to the annual value of $78.5 million for FY2024, which is 13.69% down from last year.
  • Latest data reveals that Journey Medical reported Assets Average of $83.2 million as of Q3 2025, which was up 0.14% from $83.1 million recorded in Q2 2025.
  • Journey Medical's Assets Average's 5-year high stood at $117.2 million during Q2 2022, with a 5-year trough of $64.6 million in Q3 2024.
  • Over the past 3 years, Journey Medical's median Assets Average value was $72.1 million (recorded in 2024), while the average stood at $76.9 million.
  • Its Assets Average has fluctuated over the past 5 years, first tumbled by 38.79% in 2023, then climbed by 28.72% in 2025.
  • Quarterly analysis of 5 years shows Journey Medical's Assets Average stood at $93.2 million in 2021, then grew by 14.47% to $106.7 million in 2022, then slumped by 33.07% to $71.4 million in 2023, then grew by 1.06% to $72.1 million in 2024, then increased by 28.72% to $83.2 million in 2025.
  • Its last three reported values are $83.2 million in Q3 2025, $83.1 million for Q2 2025, and $82.6 million during Q1 2025.